Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure

American Journal of Hematology

Volumn 86, Issue 3, 2011, Pages 321-323

  Sudour, Helene ^a   Kimmoun, Antoine ^a   Contet, Audrey ^b   Clement, Laurence ^b   Salmon, Alexandra ^b   Schmitt, Claudine ^b   Chastagner, Pascal ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL D ENFANTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE MACROGOL; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; NARCOTIC ANALGESIC AGENT; STEROID; VINDESINE;

ACUTE GASTROINTESTINAL GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC KIDNEY FAILURE; COLITIS; COMORBIDITY; CONTINUOUS HEMODIALYSIS; CYTOLYSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; FEBRILE PANCYTOPENIA; GRAFT VERSUS HOST REACTION; HAND FOOT SYNDROME; HUMAN; LETTER; MALE; MYELOABLATIVE CONDITIONING; PANCYTOPENIA; PARENTERAL NUTRITION; PRIORITY JOURNAL; SIDE EFFECT; STEROID THERAPY; STOMATITIS; WHOLE BODY RADIATION;

ADENINE NUCLEOTIDES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CYTARABINE; DISEASE MANAGEMENT; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKEMIA; MALE; RENAL DIALYSIS; SALVAGE THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951866233     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21965     Document Type: Letter

References (11)

1. Kantarjian HM, Jeha S, Gandhi V, et al. Clofarabine: Past, present, and future. Leuk Lymphoma 2007; 48: 1922-1930.
2. Kantarjian H, Gandhi V, Cortes J, et al. Phase II clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood 2003; 102: 2379-2386.
3. Jeha S, Gaynon PS, Razzouk BI, et al. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol 2006; 24: 1917-1923.
4. Faderl S, Gandhi V, O'Brien S, et al. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood 2005; 105: 940-947.
5. Kielstein JT, Stadler M, Czock D, et al. Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 2005; 74: 533-534.
6. Jeha S, Gandhi V, Chan K, et al. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advenced leukemia. Blood 2004; 103: 784-789.
7. Jeha S, Razzouk B, Rytting M, et al. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. J Clin Oncol 2009; 27: 4392-4397.
8. Bonate PL, Cunningham CC, gaynon P, et al. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. J Clin Pharmacol 2004; 44: 1309-1322.
9. Crews KR, Wimmer PS, Hudson JQ, et al. Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure. J Pediatr Hematol Oncol 2002; 24: 677-680.
10. Gandhi V, Kantarjian H, Faderl S, et al. Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias. Clin Cancer Res 2003; 9: 6335-6342.
11. Bonate PL, Arthaud L, Cantrell WRJr, et al. Discovery and development of clofarabine: A nucleoside analogue for treating cancer. Nat Rev Drug Discov 2006; 5: 855-863.